Dr. Grunwald is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1021 Morehead Medical Dr
Ste A
Charlotte, NC 28204Phone+1 980-442-2000Fax+1 704-355-5800
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2009 - 2013- Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2009
- Johns Hopkins University School of MedicineClass of 2006
Certifications & Licensure
MD State Medical License 2009 - 2026
NC State Medical License 2013 - 2025
FL State Medical License 2021 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplanta...Michael R Grunwald, Wei Sha, Jiaxian He, Srinivasa Sanikommu, Jonathan M Gerber
Transplantation and Cellular Therapy. 2024-12-01 - Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell Transplantation.Miranda Benfield, Jiaxian He, Justin Arnall, Whitney Kaizen, Elizabeth Jandrisevits
Transplantation and Cellular Therapy. 2024-11-05 - 2 citationsDonor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.Tania Jain, Noel Estrada-Merly, M Queralt Salas, Soyoung Kim, Jakob DeVos
Blood Advances. 2024-08-27
Abstracts/Posters
- Phase 1 Dose Escalation and Expansion Study to Determine Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the BET Inhibitor FT-1101 As a Single Agent in...Michael R. Grunwald, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Risk of Hemorrhage in Patients with Polycythemia Vera Exposed to Aspirin in Combination with Anticoagulants: Results of a Prospective, Multicenter, Observational Cohor...Michael R. Grunwald, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Patient Reported Financial Toxicity in Myeloproliferative NeoplasmsMichael R. Grunwald, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Ver...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Characteristics Associated with Hydroxyurea Treatment Change in Patients with Polycythemia Vera: An Analysis from the Reveal Study2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Real-World Risk Assessment and Treatment of Patients with Myelofibrosis at Community Oncology Practices in the United StatesClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Low-Risk Myelofibrosis Shows Evidence of Disease ProgressionOctober 11th, 2024- Sugar Companies Say the Air Is SafeJuly 8th, 2021
- HLA-Haploidentical Relative and Matched Unrelated Donor Transplant Lead to Similar Survival Outcomes in MDSApril 1st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
